ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $409,000 | -62.0% | 188,616 | -38.6% | 0.04% | -59.4% |
| Q2 2021 | $1,076,000 | -84.6% | 307,442 | -56.5% | 0.11% | -85.3% |
| Q1 2021 | $6,975,000 | -25.0% | 707,442 | -17.5% | 0.72% | -25.2% |
| Q4 2020 | $9,301,000 | +5.3% | 858,000 | 0.0% | 0.97% | +1.4% |
| Q3 2020 | $8,837,000 | -39.8% | 858,000 | +22.0% | 0.95% | -47.1% |
| Q2 2020 | $14,679,000 | +83.9% | 703,000 | -13.9% | 1.80% | +106.7% |
| Q1 2020 | $7,982,000 | +30.7% | 816,945 | +54.2% | 0.87% | +66.5% |
| Q4 2019 | $6,105,000 | +94.6% | 529,945 | -7.9% | 0.52% | +113.5% |
| Q3 2019 | $3,137,000 | -57.0% | 575,645 | -6.3% | 0.24% | -48.3% |
| Q2 2019 | $7,303,000 | +56.8% | 614,199 | -30.9% | 0.47% | +68.1% |
| Q1 2019 | $4,657,000 | +15.0% | 888,722 | -30.9% | 0.28% | +43.1% |
| Q4 2018 | $4,049,000 | -41.8% | 1,285,400 | +11.8% | 0.20% | -13.6% |
| Q3 2018 | $6,958,000 | – | 1,150,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |